Date
23 January 2018
Johnson & Johnson and GSK leaders in antibiotics research – report
Pharmaphorum reports on the leaders of the AMR Benchmark and the call for further action to combat the rise of drug-resistant bacteria.
This article covers the results of the AMR Benchmark and the number of antibiotics in the R&D pipeline. “The Netherlands-based Access to Medicine Foundation uncovered the fact that the number of antibiotics in development since 2000 has fallen.”